🇺🇸 FDA
Pipeline program

JPB898 (Induction and Maintenance)

CJPB898A12301

Phase 3 small_molecule terminated

Quick answer

JPB898 (Induction and Maintenance) for Melanoma is a Phase 3 program (small_molecule) at Sandoz Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Sandoz Pty Ltd
Indication
Melanoma
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials